Results 291 to 300 of about 7,056,691 (346)

BioPlanner: Automatic Evaluation of LLMs on Protocol Planning in Biology

Conference on Empirical Methods in Natural Language Processing, 2023
The ability to automatically generate accurate protocols for scientific experiments would represent a major step towards the automation of science. Large Language Models (LLMs) have impressive capabilities on a wide range of tasks, such as question ...
Odhran O'Donoghue, Aleksandar Shtedritski, John Ginger, Ralph Abboud, Ali E. Ghareeb, J. Booth, Samuel G. Rodriques   +6 more
semanticscholar   +1 more source

Bioaccessibility of phenolic compounds using the standardized INFOGEST protocol: A narrative review.

Comprehensive Reviews in Food Science and Food Safety, 2022
The INFOGEST protocol creation was a watershed for phenolic bioaccessibility studies. Because of this important initiative to standardize bioaccessibility studies, data comparisons between different laboratories are now expedited. It has been eight years
Gabriela Boscariol Rasera, A. D. de Camargo, Ruann Janser Soares de Castro   +2 more
semanticscholar   +1 more source

Northern Colorado Plateau Network landbird monitoring protocol science review: A summary of reviewers’ responses and recommendations

Beginning in 2020, the Northern Colorado Plateau Inventory and Monitoring Network (NCPN) partnered with the Mediterranean Coast Network (MEDN) and seven other National Park Service Inventory and Monitoring networks to review their collective landbird ...
Michael Bozek
semanticscholar   +1 more source

Comparing Bibliometric Analysis Using PubMed, Scopus, and Web of Science Databases.

Journal of Visualized Experiments, 2019
Literature databases (i.e., PubMed, Scopus, and Web of Science) differ in terms of their coverage, focus, and the tool they provide. PubMed focuses mainly on life sciences and biomedical disciplines, whereas Scopus and Web of Science are ...
S. A. S. AlRyalat, Lna Malkawi, Shaher Momani   +2 more
semanticscholar   +1 more source

Protocols for Open Science

2008
One of the strong messages that came back from the workshop we held at the BioSysBio meeting was that protocols and standards of behaviour were something that people would appreciate having available. There are many potential issues that are raised by the idea of a ‘charter’ or ‘protocol’ for open science but these are definitely things that are worth ...
openaire   +1 more source

A Backtesting Protocol in the Era of Machine Learning

The Journal of Financial Data Science, 2018
Machine learning offers a set of powerful tools that holds considerable promise for investment management. As with most quantitative applications in finance, the danger of misapplying these techniques can lead to disappointment.
R. Arnott, Campbell R. Harvey, H. Markowitz   +2 more
semanticscholar   +1 more source

Protocols for experiments in African science fiction

Scrutiny2, 2009
Abstract Africa is rich in migratory mythology that ties in with contemporary cyborg narratives, drawing strongly on motifs of transformation, hybridity, gender-blending and extra-sensory perception and offering viable alternatives to destructive techno-capitalism.
Delphi Carstens, Mer Roberts
openaire   +1 more source

Development and validation of an observation‐based protocol to measure the eight scientific practices of the next generation science standards in K‐12 science classrooms

Journal of Research in Science Teaching, 2021
Ying‐Chih Chen, Takeshi Terada
semanticscholar   +1 more source

TRANSIENCE: D3.8 – Open science protocols

Open science is a set of principles and practices to make scientific research available and accessible to everyone. This deliverable aims to explore and operationalise open science principles and practices that can support the research activities of the TRANSIENCE project.
Xexakis, Georgios, Alexandrou, Stratis
openaire   +1 more source

Will general antiviral protocols always be science fiction?

Seeds of Science, 2022
Currently, antiviral drugs are targeted at specific viruses, requiring extensive research to develop de novo before a trial molecule is approved for a single viral target. However, it is possible that a strategic asset for mainstreaming antivirals has been hiding in plain sight.
openaire   +1 more source